search
Back to results

Dietary Fat, Eicosanoids and Breast Cancer Risk

Primary Purpose

Breast Cancer

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Low Fat diet
Low Fat high n3 diet
High Fat Diet
Sponsored by
USDA Grand Forks Human Nutrition Research Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Breast Cancer focused on measuring omega-3 fatty acids, sex hormones, urinary sex hormone metabolites

Eligibility Criteria

40 Years - 70 Years (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Postmenopausal women
  • 45 to 70 years old,
  • at least one year since their last menstrual period
  • not using hormone replacement therapy,
  • BMI between 19 -29
  • willingness to discontinue use of over-the-counter medications with anti-prostaglandin activity such as aspirin or non-steroidal anti-inflammatory medications
  • consumption of a "Typical " American diet with no unusual dietary practices such as compliance with a strict vegetarian diet
  • willingness to comply with the demands of the experimental protocol.

Exclusion Criteria:

  • Smoking
  • Known disease process, and 3) Use of prescription medications, including hormone replacement therapy.

Sites / Locations

  • University of Minnesota

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm 6

Arm Type

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Arm Label

Low Fat, High Fat, Low Fat High Omega 3

Low Fat, Low Fat High Omega 3, High Fat

High Fat, Low Fat, Low Fat High Omega 3

High Fat, Low fat High Omega 3, Low Fat

Low Fat High Omega 3, High Fat, Low Fat

Low Fat High Omega 3, Low Fat, High Fat

Arm Description

See Intervention Description

See Intervention Description

See Intervention Description

See Intervention Description

See Intervention Description

See Intervention Description

Outcomes

Primary Outcome Measures

Plasma Sex Hormone Levels
E2
Estradiol

Secondary Outcome Measures

Full Information

First Posted
April 1, 2013
Last Updated
August 1, 2018
Sponsor
USDA Grand Forks Human Nutrition Research Center
search

1. Study Identification

Unique Protocol Identification Number
NCT01824498
Brief Title
Dietary Fat, Eicosanoids and Breast Cancer Risk
Official Title
Dietary Fat, Eicosanoids and Breast Cancer Risk
Study Type
Interventional

2. Study Status

Record Verification Date
August 2018
Overall Recruitment Status
Completed
Study Start Date
January 2004 (undefined)
Primary Completion Date
December 2008 (Actual)
Study Completion Date
November 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
USDA Grand Forks Human Nutrition Research Center

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The primary objective of this investigation is to determine whether diets designed to increase plasma n3 concentrations (a low fat diet, with or without n3 fatty acid enrichment), will favorably affect sex hormone distribution in women in a direction associated with reduced risk of sex hormone-mediated cancer development. Specifically, we hypothesize that an increased concentration of circulating n3 fatty acids will reduce the biochemical markers associated with increased risk for developing certain sex hormone mediated cancers such as breast cancer
Detailed Description
The guiding concept of our proposal is that both the total fat and the fatty acid composition of the diet contribute to a milieu associated with the risk for sex-hormone mediated cancers. Specifically, we hypothesize that an increased concentration of circulating n3 fatty acids will reduce the biochemical markers associated with increased risk for developing certain sex hormone mediated cancers such as breast cancer. When compared with the high fat diet, we expect n3 concentrations to increase and sex hormone levels to decrease after both low fat and low fat/n3 rich diets, with the greatest response in the low fat-n3 supplemented group. The aims of this project are: 1) to evaluate the effects of total fat and n3 fatty acid consumption on plasma and urine sex hormone concentrations in postmenopausal women, 2) to evaluate the relationship between plasma concentrations of fatty acids and plasma and urinary sex hormone concentrations, and 3) to evaluate the effects of total fat and n3 fatty acid consumption on the associations between sex hormone concentrations and urinary prostaglandin E2 and thromboxane B2 concentrations. The primary objective of this investigation is to determine whether diets designed to increase plasma n3 concentrations (a low fat diet, with or without n3 fatty acid enrichment), will favorably affect sex hormone distribution in women in a direction associated with reduced risk of sex hormone-mediated cancer development. The primary endpoints to be evaluated include plasma and urinary sex hormone concentrations as follows: Endpoints associates with increased risk factors for breast cancer risk: plasma estradiol (E2), estrone (E1), estrone sulfate (E1 sulfate), testosterone, androstenedione, sex hormone binding globulin (SHBG), dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEAS), Measures of estrogen action: plasma follicle stimulating hormone (FSH), urinary estrogen metabolites. Measures of systemic arachidonic acid-derived eicosanoids: urinary bicyclo-prostaglandin E2 (PGEa), 2,3-dinor thromboxane B2 (TXB2). Measures reflecting influence of dietary fat and fatty acid intake: plasma phospholipid, cholesterol ester, triglyceride and free fatty acid composition.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer
Keywords
omega-3 fatty acids, sex hormones, urinary sex hormone metabolites

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
18 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Low Fat, High Fat, Low Fat High Omega 3
Arm Type
Experimental
Arm Description
See Intervention Description
Arm Title
Low Fat, Low Fat High Omega 3, High Fat
Arm Type
Experimental
Arm Description
See Intervention Description
Arm Title
High Fat, Low Fat, Low Fat High Omega 3
Arm Type
Experimental
Arm Description
See Intervention Description
Arm Title
High Fat, Low fat High Omega 3, Low Fat
Arm Type
Experimental
Arm Description
See Intervention Description
Arm Title
Low Fat High Omega 3, High Fat, Low Fat
Arm Type
Experimental
Arm Description
See Intervention Description
Arm Title
Low Fat High Omega 3, Low Fat, High Fat
Arm Type
Experimental
Arm Description
See Intervention Description
Intervention Type
Other
Intervention Name(s)
Low Fat diet
Intervention Description
Low fat diet = 20% fat
Intervention Type
Other
Intervention Name(s)
Low Fat high n3 diet
Intervention Description
Low Fat high n3 diet = 20% fat + 3% n3
Intervention Type
Other
Intervention Name(s)
High Fat Diet
Intervention Description
High Fat Diet = 40% fat
Primary Outcome Measure Information:
Title
Plasma Sex Hormone Levels
Time Frame
8 weeks
Title
E2
Description
Estradiol
Time Frame
8 weeks

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Postmenopausal women 45 to 70 years old, at least one year since their last menstrual period not using hormone replacement therapy, BMI between 19 -29 willingness to discontinue use of over-the-counter medications with anti-prostaglandin activity such as aspirin or non-steroidal anti-inflammatory medications consumption of a "Typical " American diet with no unusual dietary practices such as compliance with a strict vegetarian diet willingness to comply with the demands of the experimental protocol. Exclusion Criteria: Smoking Known disease process, and 3) Use of prescription medications, including hormone replacement therapy.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Susan K Raatz, PhD, RD
Organizational Affiliation
USDA, GFHNRC
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Minnesota
City
Minneapolis
State/Province
Minnesota
ZIP/Postal Code
55455
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
21840466
Citation
McColley SP, Georgopoulos A, Young LR, Kurzer MS, Redmon JB, Raatz SK. A high-fat diet and the threonine-encoding allele (Thr54) polymorphism of fatty acid-binding protein 2 reduce plasma triglyceride-rich lipoproteins. Nutr Res. 2011 Jul;31(7):503-8. doi: 10.1016/j.nutres.2011.06.003.
Results Reference
background
PubMed Identifier
22260857
Citation
Raatz SK, Young LR, Picklo MJ Sr, Sauter ER, Qin W, Kurzer MS. Total dietary fat and fatty acid content modifies plasma phospholipid fatty acids, desaturase activity indices, and urinary prostaglandin E in women. Nutr Res. 2012 Jan;32(1):1-7. doi: 10.1016/j.nutres.2011.12.006.
Results Reference
background
PubMed Identifier
23618064
Citation
Young LR, Raatz SK, Thomas W, Redmon JB, Kurzer MS. Total dietary fat and omega-3 fatty acids have modest effects on urinary sex hormones in postmenopausal women. Nutr Metab (Lond). 2013 Apr 23;10(1):36. doi: 10.1186/1743-7075-10-36.
Results Reference
background
PubMed Identifier
21745038
Citation
Young LR, Kurzer MS, Thomas W, Redmon JB, Raatz SK. Effect of dietary fat and omega-3 fatty acids on urinary eicosanoids and sex hormone concentrations in postmenopausal women: a randomized controlled feeding trial. Nutr Cancer. 2011;63(6):930-9. doi: 10.1080/01635581.2011.589957. Epub 2011 Jul 11.
Results Reference
result

Learn more about this trial

Dietary Fat, Eicosanoids and Breast Cancer Risk

We'll reach out to this number within 24 hrs